Published in World J Gastroenterol on May 28, 2014
Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Lab Invest (2015) 0.86
Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. World J Gastroenterol (2015) 0.78
Biliary Cast Syndrome: Hepatic Artery Resistance Index, Pathological Changes, Morphology and Endoscopic Therapy. Chin Med J (Engl) (2015) 0.75
Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol (2016) 0.75
Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation. Transplant Direct (2017) 0.75
Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84
Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol (1991) 2.67
A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg (1979) 2.66
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg (2010) 2.30
Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02
Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96
Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl (2012) 1.92
Biliary strictures following liver transplantation: past, present and preventive strategies. Liver Transpl (2008) 1.81
Ischemia and reperfusion injury in liver transplantation. Transplant Proc (2005) 1.77
Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int (2009) 1.77
Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75
Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol (1994) 1.75
CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol (2010) 1.69
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Ischemic cholangitis in hepatic allografts. Mayo Clin Proc (1992) 1.66
Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60
Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59
A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation. Hepatology (1995) 1.59
Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg (2008) 1.49
Management of biliary tract complications after orthotopic liver transplantation. Clin Transplant (2004) 1.48
Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology (1995) 1.47
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol (2012) 1.44
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39
The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection. Transplantation (2002) 1.38
Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl (2008) 1.36
Biliary tract complications after liver transplantation: a review. Dig Surg (2008) 1.36
Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl (2006) 1.32
An endoscopic approach to biliary complications following orthotopic liver transplantation. Liver Int (2003) 1.31
A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology (1989) 1.30
Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl (2008) 1.30
Biliary complications of orthotopic liver transplantation. Dig Dis (1999) 1.29
Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant (2013) 1.29
Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology (1991) 1.27
Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol (1987) 1.24
Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg (1992) 1.23
Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage. Transplantation (2004) 1.23
Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology (2000) 1.17
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology (1996) 1.14
Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation (2006) 1.14
Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts. Hepatology (1995) 1.12
The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg (2010) 1.11
The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation (1993) 1.11
Endoscopic management of biliary strictures after liver transplantation. World J Gastroenterol (2009) 1.11
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg (2011) 1.11
Biliary strictures after liver transplantation. Gut Liver (2011) 1.09
Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant (2012) 1.09
Intrahepatic biliary strictures after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.05
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl (2003) 1.03
Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am J Transplant (2008) 1.02
Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl (2007) 1.01
Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis. PLoS One (2011) 1.00
Basal activity of Kupffer cells increases with old age. J Gerontol A Biol Sci Med Sci (2007) 1.00
Recurrence rate of anastomotic biliary strictures in patients who have had previous successful endoscopic therapy for anastomotic narrowing after orthotopic liver transplantation. Endoscopy (2006) 0.98
Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation (2011) 0.98
Prevention and treatment of ischemia of the liver. Surg Gynecol Obstet (1987) 0.98
Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg (1992) 0.97
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation (2008) 0.97
Biliary complications after liver transplantation from maastricht category-2 non-heart-beating donors. Transplantation (2008) 0.96
Ischemic cholangiopathy after liver transplantation. Hepatobiliary Pancreat Dis Int (2005) 0.96
Endoscopic management of biliary complications after orthotopic liver transplantation. Hepatogastroenterology (1997) 0.95
Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant (2008) 0.95
Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology (1996) 0.95
Protective effect of the lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology (1994) 0.95
Bile duct strictures after liver transplantation: a changing landscape of the Achilles' heel. Liver Transpl (2006) 0.94
Ischemic cholangiopathy. J Hepatol (2006) 0.94
Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant (2010) 0.93
Influence of marginal donors on liver preservation injury. Transplantation (2002) 0.92
Effect of ischemia-reperfusion on bile canalicular F-actin microfilaments in hepatocytes of human liver allograft: image analysis by confocal laser scanning microscopy. Dig Dis Sci (2001) 0.92
The trouble with kidneys derived from the non heart-beating donor: a single center 10-year experience. Transplantation (2000) 0.92
Intrahepatic biliary strictures after liver transplantation. Radiology (1994) 0.91
The relation of mesenchymal cell products to hepatic epithelial systems. Prog Liver Dis (1990) 0.90
Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology (1998) 0.89
Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice. Hepatology (2006) 0.88
Ischemia/reperfusion injury of the liver: pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis. Acta Gastroenterol Belg (2001) 0.87
Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy (1994) 0.87
Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: an analysis of 1,113 liver transplantations at a single center. Transplantation (2005) 0.87
Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation. Ann Surg (1999) 0.86
[Etiologic factors and incidence of ischemic type biliary lesions (ITBL) after liver transplantation]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.86
A model for provoking ischemic necrosis in rat liver parenchyma and its quantitative analysis. Exp Pathol (1982) 0.85
Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg (2011) 0.85
Acute and chronic hepatic allograft rejection: pathology and classification. Liver Transpl Surg (1999) 0.84
Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited? Hepatology (1995) 0.84
The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. Am J Transplant (2011) 0.84
Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int (2006) 0.83
Cellular energy metabolism during hypoxia. Crit Care Med (1991) 0.82
Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl (2008) 0.82
Ischemic type biliary lesions in histidine-tryptophan-ketoglutarate (HTK) preserved liver grafts. Int J Artif Organs (2006) 0.82
Management of biliary complications in the liver transplant patient. Gastroenterol Hepatol (N Y) (2010) 0.81